α-Glutathione S-transferase levels in chronic hepatitis C infection and the effect of α-interferon therapy

Clinica Chimica Acta

Volumn 253, Issue 1-2, 1996, Pages 171-180

  Thorburn, Douglas ^a   Bird, George L A ^a   Spence, Elizabeth ^a   MacSween, Roderick N M ^a   Mills, Peter R ^a,b  

^a WESTERN INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alanine aminotransferase; Hepatitis C; Glutathione S transferase; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; GLUTATHIONE TRANSFERASE; RECOMBINANT ALPHA2A INTERFERON;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATITIS C; HISTOLOGY; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER INJURY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE;

HEPATITIS C VIRUS;

EID: 0030607237     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06337-1     Document Type: Article

References (20)

1. [1] Seeff LB, Buskell-Bales Z, Wright EC et al. Long term mortality after transfusion-related non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
2. [2] Alter MJ, Margoyles HS, Krawcyznski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
3. [3] Benhamou JP. Viral hepatitis: chairman's introduction. Gut 1993;34(Suppl 2):IV.
4. [4] Alberti A, Morsica G, Chemello L et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:697-698.
5. [5] Persico M, Romano M. Alanine aminotransferase measurements and histological disease in hepatitis C. Lancet 1993;342:1369-1370.
6. [6] Beckett GJ, Foster GR, Hussey AJ et al. Plasma glutathione s-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damage. Clin Chem 1989;35:2186-2189.
7. [7] Hayes PC, Hussey AJ, Keating J et al. Glutathione s-transferase levels in autoimmune chronic active hepatitis: a more sensitive index of hepatocellular damage than aspartate transaminase. Clin Chim Acta 1988;172:211-216.
8. [8] Trull AK, Facey SP, Rees GW et al. Serum α-glutathione s-transferase: a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 1994;58:1345-1351.
9. [9] Tine F, Magrin S, Kraksy A et al. Interferon for non-A non-B chronic hepatitis: a meta-analysis of randomized clinical trials. J Hepatol 1991;13:192-199.
10. [10] Diamen M, Kuipers HTM, Zaaiger HL et al. The second international quality control study on the Eurohep HCV-RNA reference panel. J Clin Microbiol (in press).
11. [11] Davidson F, Simmonds P, Ferguson JC et al. Survey of major genotypes and subtypes of HCV using RFLP of sequences amplified from 5′ non-coding region. J Gen Virol 1995;76:1197-1204.
12. [12] Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
13. [13] Beckett GJ and Hayes JD. Glutathione .s-transferase: biomedical applications. Adv Clin Chem 1993;30:281-380.
14. [14] Stanley AJ, Haydon GH, Pins J, Simmonds P, Hayes PC. Liver histology in patients with hepatitis C (HCV) and normal transaminase levels. Gut 1995;36(Suppl 1):A2.
15. [15] Healey CJ, Chapman RWG, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1995;37:274-278.
16. [16] Zignego AL, Foschi M, Laffi G et al. Inapparent hepatitis B virus infection and hepatitis C virus replication in alcohol subjects with and without liver disease. Hepatology 1994;19:577-582.
17. [17] Fog T, Kanel G, Conrad A et al. Clinical significance of concomitant hepatitis C infection in patients with alcohol liver disease. Hepatology 1994;19:554-557.
18. [18] Nelson DR, Lim HL, Oliver D et al. α-Glutathione S-transferase as a marker of hepato-cellular damage in chronic hepatitis C virus infection. Am J Clin Pathol 1995;104:193-198.
19. [19] Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
20. [20] Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: diagnosis, grading, staging. Hepatology 1994;19:1513-1520.